SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015877
Filing Date
2021-08-05
Accepted
2021-08-05 16:21:27
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q advm-20210630.htm   iXBRL 10-Q 1283172
2 EX-10.1 ex101firstamendment-health.htm EX-10.1 176704
3 EX-10.2 ex102pattersonconsultingag.htm EX-10.2 52901
4 EX-10.3 ex103clark_juliexofferlett.htm EX-10.3 35106
5 EX-10.4 ex104promotionletterjuliec.htm EX-10.4 33816
6 EX-10.5 ex105changeincontrolagreem.htm EX-10.5 63267
7 EX-10.6 ex106offerletterchrisderes.htm EX-10.6 40305
8 EX-10.7 ex107changeincontrol-chris.htm EX-10.7 62237
9 EX-31.1 advm-20210630ex311.htm EX-31.1 10213
10 EX-31.2 advm-20210630ex312.htm EX-31.2 10235
11 EX-32.1 advm-20210630ex321.htm EX-32.1 5435
12 EX-32.2 advm-20210630ex322.htm EX-32.2 5230
18 GRAPHIC ex101exa.jpg GRAPHIC 81480
19 GRAPHIC ex101sch1.jpg GRAPHIC 138669
20 GRAPHIC ex101sch1_2f.jpg GRAPHIC 124220
  Complete submission text file 0001628280-21-015877.txt   5414932

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20210630.xsd EX-101.SCH 23222
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20210630_cal.xml EX-101.CAL 53816
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20210630_def.xml EX-101.DEF 91191
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20210630_lab.xml EX-101.LAB 345580
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20210630_pre.xml EX-101.PRE 214459
21 EXTRACTED XBRL INSTANCE DOCUMENT advm-20210630_htm.xml XML 585039
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 211148546
SIC: 2836 Biological Products, (No Diagnostic Substances)